Vornorexant is an orexin receptor antagonist used for the treatment of insomnia. It works by blocking orexin receptors (OX1R and OX2R), which are involved in wakefulness regulation, thereby promoting sleep onset and maintenance. It is being developed as a therapeutic option to improve sleep quality in patients with sleep disorders. The directory classifies it as a under development API with a synthetic source/manufacturing origin. Other names for this substance include Vornorexant free base and Vorzzz. Its PubChem CID is 137419776.
Vornorexant
| CAS No | 2265899-49-6 |
|---|---|
| Molecular Formula | C23H22FN7O2 |
| Molecular Weight | 447.5 g/mol |
| Synonyms | [(2S)-2-[[3-(5-fluoro-2-pyridinyl)pyrazol-1-yl]methyl]-1,3-oxazinan-3-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Vornorexant is an orexin receptor antagonist used for the treatment of insomnia. It works by blocking orexin receptors (OX1R and OX2R), which are involved in wakefulness regulation, thereby promoting sleep onset and maintenance.
The listed CAS number is 2265899-49-6.
The listed molecular formula is C23H22FN7O2.
The listed molecular weight is 447.5 g/mol.
[(2S)-2-[[3-(5-fluoro-2-pyridinyl)pyrazol-1-yl]methyl]-1,3-oxazinan-3-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone.
The source lists Vornorexant free base and Vorzzz.